Primary mutations selected in vitro with raltegravir confer large fold changes in susceptibility to first-generation integrase inhibitors, but minor fold changes to inhibitors with second-generation resistance profiles
(Q34112243)
scientific article
scientific article
Language:
other details
| description | scientific article |
External Links
| (P356) |
10.1016/J.VIROL.2010.03.034
|
| (P698) |
20421122
|
| (P5875) |
43345348
|
| (P8608) |
release_sdvd5nfcwjhfpdce5reo7kmkx4
|